Insider Trading History of Lamattina John L

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Lamattina John L since 2005. This trader's CIK number is 1216074. At the time of last reporting, Lamattina John L was the Director of Ligand Pharmaceuticals Inc. (stock ticker symbol LGND). Also see all insider trading activities at Ligand Pharmaceuticals Inc.

Note that in the past LAMATTINA JOHN L also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Ligand Pharmaceuticals Inc (LGND) by Lamattina John L

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2024 LGND 0 $0 2,406 $297,501 2,406 $125,833
2021 LGND 0 $0 4,835 $782,578 4,835 $156,170
2019 LGND 0 $0 0 $0 2,500 $80,750
2018 LGND 0 $0 10,670 $2,164,935 10,670 $125,657
2017 LGND 0 $0 4,000 $559,160 4,000 $40,480
2014 LGND 0 $0 5,000 $394,150 5,000 $44,850
2011 LGND 10,000 $98,190 0 $0 0 $0

Yearly summary of insider trading at Pfizer Inc (PFE) by Lamattina John L

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2007 PFE 0 $0 49,866 $1,321,279 13,800 $253,230
2005 PFE 0 $0 39,789 $1,106,731 0 $0

Yearly summary of insider trading at Human Genome Sciences Inc (HGSI) by Lamattina John L

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2011 HGSI 0 $0 0 $0 12,009 $25,098
2009 HGSI 10,000 $7,190 0 $0 0 $0
2008 HGSI 20,000 $43,700 0 $0 0 $0

Yearly summary of insider trading at Immunome Inc. (IMNM) by Lamattina John L

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2021 IMNM 5,440 $100,694 0 $0 0 $0


Insider trading activities at 4 companies by Lamattina John L:

1. Ligand Pharmaceuticals Inc (LGND)

2. Pfizer Inc (PFE)

3. Human Genome Sciences Inc (HGSI)

4. Immunome Inc. (IMNM)

Table 1. Insider trading of Ligand Pharmaceuticals Inc (LGND) by Lamattina John L

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2024-11-27 LGND Option Ex 2,406 52.30 125,833
2024-11-27 LGND Sale 2,406 123.65 297,501
2021-11-16 LGND Option Ex 4,835 32.30 156,170
2021-11-16 LGND Sale 4,835 161.86 782,578
2019-08-01 LGND Option Ex 2,500 32.30 80,750
2018-09-04 LGND Sale 3,335 254.96 850,291
2018-09-04 LGND Option Ex 3,335 12.53 41,787
2018-06-04 LGND Option Ex 4,000 12.53 50,120
2018-06-04 LGND Sale 4,000 194.51 778,040
2018-03-05 LGND Option Ex 3,335 10.12 33,750
2018-03-05 LGND Sale 3,335 160.90 536,604
2017-11-17 LGND Option Ex 4,000 10.12 40,480
2017-11-17 LGND Sale 4,000 139.79 559,160
2014-03-18 LGND Option Ex 5,000 8.97 44,850
2014-03-18 LGND Sale 5,000 78.83 394,150
2011-03-11 LGND Buy 10,000 9.82 98,190

Table 2. Insider trading of Pfizer Inc (PFE) by Lamattina John L

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2007-06-15 PFE Sale 36,066 26.48 955,027
2007-02-07 PFE Option Ex 13,800 18.35 253,230
2007-02-07 PFE Sale 13,800 26.54 366,252
2005-05-06 PFE Sale 39,789 27.82 1,106,731

Table 3. Insider trading of Human Genome Sciences Inc (HGSI) by Lamattina John L

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2011-08-10 HGSI Option Ex 12,009 2.09 25,098
2009-03-13 HGSI Buy 10,000 .72 7,190
2008-11-12 HGSI Buy 20,000 2.19 43,700

Table 4. Insider trading of Immunome Inc. (IMNM) by Lamattina John L

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2021-05-24 IMNM Buy 5,440 18.51 100,694

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lamattina John L (Director of Ligand Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.